Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its second quarter 2025 financial results announcement and corporate update for Wednesday, August 6, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Following the live presentation, a recorded version will be available on the company's website and remain accessible for approximately 90 days.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 e un aggiornamento aziendale per mercoledì 6 agosto 2025. La società terrà una diretta webcast alle 13:30 PT / 16:30 ET. Dopo la presentazione dal vivo, una registrazione sarà disponibile sul sito web dell'azienda e resterà accessibile per circa 90 giorni.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programado el anuncio de resultados financieros del segundo trimestre de 2025 y una actualización corporativa para el miércoles 6 de agosto de 2025. La compañía realizará una transmisión en vivo a las 1:30 p.m. PT / 4:30 p.m. ET. Después de la presentación en vivo, una versión grabada estará disponible en el sitio web de la empresa y permanecerá accesible por aproximadamente 90 días.
Tarsus Pharmaceuticals (NASDAQ: TARS)는 2025년 2분기 재무 실적 발표 및 회사 업데이트를 2025년 8월 6일 수요일에 예정했습니다. 회사는 오후 1:30 PT / 오후 4:30 ET에 라이브 웹캐스트를 진행할 예정입니다. 라이브 발표 후 녹화된 버전이 회사 웹사이트에 게시되며 약 90일간 이용할 수 있습니다.
Tarsus Pharmaceuticals (NASDAQ : TARS) a programmé l'annonce des résultats financiers du deuxième trimestre 2025 et une mise à jour de l'entreprise pour le mercredi 6 août 2025. La société organisera une webdiffusion en direct à 13h30 PT / 16h30 ET. Après la présentation en direct, une version enregistrée sera disponible sur le site web de l'entreprise et restera accessible pendant environ 90 jours.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 und ein Unternehmensupdate für Mittwoch, den 6. August 2025 geplant. Das Unternehmen wird eine Live-Webcast um 13:30 Uhr PT / 16:30 Uhr ET veranstalten. Nach der Live-Präsentation wird eine Aufzeichnung auf der Website des Unternehmens verfügbar sein und etwa 90 Tage zugänglich bleiben.
- None.
- None.
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus Pharmaceuticals (TARS) report Q2 2025 earnings?
How can investors access the Tarsus Pharmaceuticals Q2 2025 earnings call?
How long will the Tarsus Pharmaceuticals Q2 2025 earnings call recording be available?
What will be discussed during the Tarsus Pharmaceuticals August 6 webcast?
